We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.79%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$183M
AUM Growth
+$18K
(+0.01%)
Cap. Flow
-$5.97M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
75.56%
Holding
62
New
2
Increased
6
Reduced
25
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$228K |
| 2 |
Stryker
SYK
|
+$206K |
| 3 |
Applied Optoelectronics
AAOI
|
+$90.5K |
| 4 |
GE Aerospace
GE
|
+$51.9K |
| 5 |
United Parcel Service
UPS
|
+$48.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.44M |
| 2 |
Idexx Laboratories
IDXX
|
+$1.24M |
| 3 |
Adobe
ADBE
|
+$1.05M |
| 4 |
Eastman Chemical
EMN
|
+$291K |
| 5 |
Verizon
VZ
|
+$252K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.29% |
| 2 | Technology | 26.17% |
| 3 | Communication Services | 8.28% |
| 4 | Industrials | 3.73% |
| 5 | Consumer Discretionary | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $59.5M | 32.52% |
458,424
-11,750
| -2% | -$1.44M |
|
|
2
Idexx Laboratories
IDXX
$43B
| $18.1M | 9.86% |
111,825
-7,630
| -6% | -$1.24M |
|
|
3
Adobe
ADBE
$86.8B
| $15.7M | 8.56% |
110,790
-7,700
| -6% | -$1.05M |
|
4
Microsoft
MSFT
$2.9T
| $8.64M | 4.72% |
125,415
-550
| -0.4% | -$37.8K |
|
5
Apple
AAPL
$4.79T
| $8M | 4.37% |
222,304
-2,188
| -1% | -$80.9K |
|
6
Alphabet (Google) Class C
GOOG
$4.17T
| $6.27M | 3.43% |
138,040
-1,700
| -1% | -$77.8K |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.17T
| $6.11M | 3.34% |
131,520
-1,700
| -1% | -$79.5K |
|
8
Intuitive Surgical
ISRG
$122B
| $5.82M | 3.18% |
55,989
| – | – |
|
9
Paychex
PAYX
$39.4B
| $5.33M | 2.91% |
93,645
-1,800
| -2% | -$106K |
|
10
Cisco
CSCO
$442B
| $4.89M | 2.67% |
156,104
-1,112
| -0.7% | -$36.2K |
|
11
Booking.com
BKNG
$138B
| $4.4M | 2.4% |
58,750
| – | – |
|
|
12
United Parcel Service
UPS
$98.5B
| $2.76M | 1.51% |
24,936
+451
| +2% | +$48.2K |
|
13
Qualcomm
QCOM
$185B
| $2.54M | 1.39% |
46,096
-3,403
| -7% | -$190K |
|
14
Enbridge
ENB
$123B
| $2.5M | 1.36% |
62,705
+973
| +2% | +$39.2K |
|
15
Johnson & Johnson
JNJ
$615B
| $2.1M | 1.15% |
15,880
-750
| -5% | -$95.7K |
|
|
POT
16
DELISTED
Potash Corp Of Saskatchewan
POT
| $2.06M | 1.13% |
126,618
-14,982
| -11% | -$248K |
|
|
MON
17
DELISTED
Monsanto Co
MON
| $1.86M | 1.02% |
15,750
-600
| -4% | -$70K |
|
18
AT&T
T
$160B
| $1.75M | 0.95% |
61,248
+132
| +0.2% | +$3.89K |
|
19
Tompkins Financial
TMP
$1.34B
| $1.61M | 0.88% |
20,450
-1,200
| -6% | -$96.6K |
|
|
20
GE Aerospace
GE
$354B
| $1.59M | 0.87% |
12,324
+379
| +3% | +$51.9K |
|
21
Quanta Services
PWR
$96.5B
| $1.55M | 0.85% |
47,250
| – | – |
|
22
T. Rowe Price
TROW
$24.9B
| $1.44M | 0.79% |
19,400
| – | – |
|
23
Pfizer
PFE
$141B
| $1.18M | 0.65% |
37,104
-4,534
| -11% | -$143K |
|
24
Amazon
AMZN
$2.63T
| $1.11M | 0.61% |
23,000
| – | – |
|
|
25
Verizon
VZ
$185B
| $1.02M | 0.56% |
22,842
-5,420
| -19% | -$252K |
|
Similar funds
SC
SC
RAM
AGP
SFPG
TP
S
SS
Bourne Lent Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Bourne Lent Asset Management held 62 positions worth $183M, up 0.01% from $183M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Bourne Lent Asset Management withdrew a net $5.97M in Q2 2017, closing 4 positions and reducing 25 holdings. Its most notable exit was Eastman Chemical, an estimated $291K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Bourne Lent Asset Management opened a new position in Tesla worth $250K.
- Bourne Lent Asset Management's largest Q2 2017 buy was Tesla: 10,350 shares worth $250K.
- Bourne Lent Asset Management added most to Applied Optoelectronics in Q2 2017, an estimated $90.5K increase.
- Bourne Lent Asset Management's biggest Q2 2017 reduction was Celgene Corp, cutting an estimated $1.44M.
- Bourne Lent Asset Management fully exited Eastman Chemical in Q2 2017, selling an estimated $291K.
- Bourne Lent Asset Management's ten largest holdings make up 76% of its $183M portfolio in Q2 2017.
- Bourne Lent Asset Management opened 2 new positions and closed 4 in Q2 2017.
- Bourne Lent Asset Management's portfolio value rose 0.01% quarter-over-quarter to $183M.
Based on Bourne Lent Asset Management's 13F filing for Q2 2017, filed 20 Jul 2017.